Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Strongyloides stercoralis infection and long-term follow-up in a privately-owned dog from north-west of Italy.
Vet Ital
September 2023
Department of Veterinary Sciences, University of Turin, Largo P. Braccini, 2-5, 10095, Grugliasco, Italy.
Article Synopsis
- * An 8-month-old French Bulldog showed symptoms like chronic cough and diarrhea; testing revealed Strongyloides stercoralis larvae, indicating a parasitic infection that led to enteropathy and bronchopneumonia.
- * Treatment with fenbendazole was initially ineffective, but two doses of ivermectin successfully resolved the dog’s symptoms, and follow-up tests confirmed the absence of the parasite after six months.
Strongyloides stercoralis in two dogs from a household in temperate Australia.
Aust Vet J
July 2024
Sydney School of Veterinary Science, Faculty of Science, University of Sydney, Sydney, New South Wales, Australia.
Strongyloides stercoralis is parasite affecting both humans and dogs and is most prevalent in tropical and subtropical areas of Australia. This case report describes two dogs from a household in Sydney, New South Wales, one with chronic gastrointestinal signs and the other who was asymptomatic who were subsequently diagnosed with S. stercoralis.
View Article and Find Full Text PDFA Rare Case of Hyperinfection in a Diabetic Patient from Romania-Case Report and Review of the Literature.
Pathogens
March 2023
Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania.
Severe cases of strongyloidiasis are most often associated with multiple causes of immune suppression, such as corticoid treatment and HTLV (human T-lymphotropic virus) coinfection. Diabetes is not traditionally considered a risk factor for the development of severe strongyloidiasis. We report a rare case of autochthonous severe strongyloidiasis in Romania, a European country with a temperate climate.
View Article and Find Full Text PDFPrevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study.
BMC Nephrol
February 2023
Division of Prison Health, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Background: Strongyloidiasis is an infectious disease that can be fatal in immunocompromised patients. Patients with end-stage renal failure who are on dialysis have a considerably weakened immune system, and organ transplantation is a major risk factor for severe strongyloidiasis. Knowledge of the local epidemiology in tropical and subtropical areas is an essential prerequisite for designing an appropriate strategy to prevent this potentially lethal complication.
View Article and Find Full Text PDFA case of induced duodenitis and pancreatitis.
IDCases
February 2022
Department of Infectious Disease, Rutgers - RWJBH Newark Beth Israel Medical Center, Newark, NJ, United States.
Strongyloidiasis is endemic in tropical and sub-tropical regions however cases of strongyloidiasis have been reported in temperate climates. Corticosteroid use, immunosuppression, infection with human T-lymphotropic virus type 1 (HTLV1), and chronic alcohol use are the most common and well-established risk factors for strongyloidiasis. Due to characteristic features of hyperinfection and dissemination, it can potentially cause a lethal infection in an immunocompromised individual.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!